Should therapy of ovarian cancer patients be individualized based on underlying genetic defects?

Gordon Mills, R. Schmandt, D. Gershenson, R. C. Bast

Research output: Contribution to journalEditorial

4 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)2286-2288
Number of pages3
JournalClinical Cancer Research
Volume5
Issue number9
StatePublished - Sep 28 1999
Externally publishedYes

Fingerprint

Predictive Value of Tests
Nucleic Acid Hybridization
Individuality
Ovarian Neoplasms
Therapeutics

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Should therapy of ovarian cancer patients be individualized based on underlying genetic defects? / Mills, Gordon; Schmandt, R.; Gershenson, D.; Bast, R. C.

In: Clinical Cancer Research, Vol. 5, No. 9, 28.09.1999, p. 2286-2288.

Research output: Contribution to journalEditorial

Mills, Gordon ; Schmandt, R. ; Gershenson, D. ; Bast, R. C. / Should therapy of ovarian cancer patients be individualized based on underlying genetic defects?. In: Clinical Cancer Research. 1999 ; Vol. 5, No. 9. pp. 2286-2288.
@article{a0f97c3106d049dabc9950570861f632,
title = "Should therapy of ovarian cancer patients be individualized based on underlying genetic defects?",
author = "Gordon Mills and R. Schmandt and D. Gershenson and Bast, {R. C.}",
year = "1999",
month = "9",
day = "28",
language = "English (US)",
volume = "5",
pages = "2286--2288",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "9",

}

TY - JOUR

T1 - Should therapy of ovarian cancer patients be individualized based on underlying genetic defects?

AU - Mills, Gordon

AU - Schmandt, R.

AU - Gershenson, D.

AU - Bast, R. C.

PY - 1999/9/28

Y1 - 1999/9/28

UR - http://www.scopus.com/inward/record.url?scp=0032882879&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032882879&partnerID=8YFLogxK

M3 - Editorial

C2 - 10499594

AN - SCOPUS:0032882879

VL - 5

SP - 2286

EP - 2288

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 9

ER -